The Chinese Antibody Society Inc, located in Cambridge, Massachusetts, is dedicated to advancing public knowledge of therapeutic antibodies and promoting antibody drug-based therapies. With an operating budget of $230.3K and total revenue of $233.6K for the filing year 2024, the organization provides communication and networking platforms for its global members. It does not rely on a single funder for 50% or more of its revenue. For more information, visit their website at chineseantibody.org.